Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/19/2012 | CN101864437B Glyphosate-resistant 5-enolpyruvyl-shikimate-3-phosphate synthase gene and application thereof |
09/19/2012 | CN101864405B Endo-beta-1,4-glucanase from odontotermes formosanus, encoding gene, vector and application |
09/19/2012 | CN101845499B Primer pair for assisting for screening wheat powdery mildew and its uses |
09/19/2012 | CN101787366B DNA fragment for peculiarly inhibiting Rab27B gene expression and application thereof |
09/19/2012 | CN101760468B Halogenohydrin dehalogenase mutant strain, halogenohydrin dehalogenase mutant and preparation method and application thereof |
09/19/2012 | CN101724625B Method for purifying total nucleic acid by using gold-magnetic particles |
09/19/2012 | CN101643749B Adeno-associated virus carrier, preparation method thereof and application |
09/19/2012 | CN101633926B Mutation gene related to dentinogenesis imperfecta type II and detection method thereof |
09/19/2012 | CN101629176B Method for cultivating rice with abortive floral organs and special DNA segment of rice |
09/19/2012 | CN101624568B Nanometer molecular biosensor, preparation method and application thereof |
09/19/2012 | CN101619307B Protein, gene and recombinant vector of Estp mutant, application and preparation method thereof |
09/19/2012 | CN101538567B Method for quickly processing filter-type micro nucleic acid clinical samples |
09/19/2012 | CN101432426B Primer and probe for detection of mycobacterium intracellulare, and method for detection of mycobacterium intracellulare by using the primer and probe |
09/19/2012 | CN101422620B Cryptosporidum parvum bivalent nucleic acid vaccine and preparation method thereof |
09/18/2012 | US8269081 Maize variety hybrid X8M165 |
09/18/2012 | US8269080 Inbred maize variety PH18T3 |
09/18/2012 | US8269079 Plants and seeds of hybrid corn variety CH354755 |
09/18/2012 | US8269076 Compositions and methods for altering tocotrienol content |
09/18/2012 | US8269075 Cotton variety 09R999B2R2 |
09/18/2012 | US8269074 Soybean cultivar 90282601 |
09/18/2012 | US8269073 Soybean variety A1015632 |
09/18/2012 | US8269072 Soybean variety A1016117 |
09/18/2012 | US8269071 Soybean variety A1015669 |
09/18/2012 | US8269070 Soybean variety A1015492 |
09/18/2012 | US8269069 Modified Bacillus thuringiensis cry proteins that inhibit coleopterans |
09/18/2012 | US8269068 Mutant hydroxyphenylpyruvate dioxygenase polypeptides and methods of use |
09/18/2012 | US8269066 Nitrate reductases from red algae, compositions and methods of use thereof |
09/18/2012 | US8269065 Nucleic acids and proteins associated with sucrose degradation in coffee |
09/18/2012 | US8269064 Transformed plant expressing a mutansucrase and synthesizing a modified starch |
09/18/2012 | US8269063 Methods for identifying proteins with starch phosphorylating enzymatic activity |
09/18/2012 | US8269061 Selective ablation of diploid embryos |
09/18/2012 | US8268987 Reverse transcription primers and methods of design |
09/18/2012 | US8268986 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA) |
09/18/2012 | US8268985 siRNA targeting amyloid beta (A4) precursor protein (APP) |
09/18/2012 | US8268979 Human MutY |
09/18/2012 | US8268976 Flea GABA receptor subunit nucleic acid molecules |
09/18/2012 | US8268966 human C-type lectin; diagnosis, prevention and/or treatment of neoplastic disorders and diseases |
09/18/2012 | US8268798 Low density lipoprotein receptor-mediated siRNA delivery |
09/18/2012 | US8268796 Lipophilic nucleic acid delivery vehicle and methods of use thereof |
09/18/2012 | US8268795 Emergence of a R-type CA2+ channel (CAV 2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage |
09/18/2012 | US8268793 RNA antagonist compounds for the modulation of HER3 |
09/18/2012 | US8268622 EPSPS mutants |
09/18/2012 | US8268620 OCT4 and SOX2 with SV40 T antigen produce pluripotent stem cells from primate somatic cells |
09/18/2012 | US8268618 Repressing endogenous CCR5 gene expression in cells using engineered zinc finger proteins |
09/18/2012 | US8268617 Anti-IGF-I receptor antibodies, DNAs, vectors, host cells and genetic constructs |
09/18/2012 | US8268616 Method for tracing gram-negative bacteria inside animal model using stable and bioluminescence-based expression system therefor |
09/18/2012 | US8268615 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide |
09/18/2012 | US8268610 Nucleic acids useful in the manufacture of oil |
09/18/2012 | US8268607 Methods and organisms for converting synthesis gas or other gaseous carbon sources and methanol to 1,3-butanediol |
09/18/2012 | US8268606 Polypeptides having endoglucanase activity and polynucleotides encoding same |
09/18/2012 | US8268605 Thermococcus mutant genetic engineering; heat resistance |
09/18/2012 | US8268598 Mutant Δ5 desaturases mutated in the heme-binding motif (HPGG) and their use in making polyunsaturated fatty acids |
09/18/2012 | US8268596 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
09/18/2012 | US8268594 pyrC as a selection marker in Escherichia coli |
09/18/2012 | US8268591 Compositions and methods for producing inhibitors of vascular endothelial growth factor activity |
09/18/2012 | US8268589 Polypeptides having endoglucanase activity and polynucleotides encoding same |
09/18/2012 | US8268588 Methods and compositions for the prevention and treatment of anemia |
09/18/2012 | US8268587 Immunosuppressive polypeptides and nucleic acids |
09/18/2012 | US8268585 Chrysosporium mutants for use as bioreactor in production/fermentation of heterologous polypeptides |
09/18/2012 | US8268583 Cell with improved secretion mediated by MrgA protein or homologue |
09/18/2012 | US8268582 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy |
09/18/2012 | US8268575 NAD biosynthesis systems |
09/18/2012 | US8268558 Internal calibration standards for electrophoretic analyses |
09/18/2012 | US8268555 Method for combined sequential agent delivery and electroporation for cell structures and use thereof |
09/18/2012 | US8268331 Nucleic acid molecules and polypeptides for immune modulation |
09/18/2012 | US8268329 Modified Vaccinia ankara virus variant |
09/18/2012 | US8268325 Modified Vaccinia Ankara virus variant |
09/18/2012 | US8268324 Modified galectin 9 proteins and use thereof |
09/18/2012 | US8268313 Methods for using inhibitors of vascular endothelial growth factor activity |
09/18/2012 | US8268312 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof |
09/18/2012 | US8268308 Means for the diagnosis and therapy of CTCL |
09/18/2012 | US8268245 Methods and devices for determining analytes in liquids of small volumes |
09/18/2012 | CA2769991A1 Met inhibitors for enhancing radiotherapy efficacy |
09/18/2012 | CA2700055C Truncated secretory aspartyl proteinase 2 |
09/18/2012 | CA2647086C Identification of a jak2 mutation in polycythemia vera |
09/18/2012 | CA2614326C Compositions and methods relating to orthogonal ribosome mrna pairs |
09/18/2012 | CA2603414C Anti-cd20 monoclonal antibody |
09/18/2012 | CA2517274C Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
09/18/2012 | CA2516157C Expression vectors comprising the mcmv ie2 promoter |
09/18/2012 | CA2514303C Synthetic single domain polypeptides mimicking apolipoprotein e and methods of use |
09/18/2012 | CA2474146C A method for evolving a cell having desired phenotype and evolved cells |
09/18/2012 | CA2462610C Specific binding agents of human angiopoietin-2 |
09/18/2012 | CA2454750C Immunologically significant herpes simplex virus antigens and methods for using same |
09/18/2012 | CA2447222C Polynucleotide sequencing method |
09/18/2012 | CA2445746C Chimeric immunoreceptor useful in treating human cancers |
09/18/2012 | CA2424602C Antibody composition-producing cell |
09/18/2012 | CA2396691C Enhanced production of lipids containing polyenoic fatty acids by high density cultures of eukaryotic microbes in fermentors |
09/18/2012 | CA2383136C Obg3 globular head and uses thereof for decreasing body mass |
09/18/2012 | CA2378943C Super-active porcine growth hormone releasing hormone analog |
09/18/2012 | CA2374482C Methods and materials for the synthesis of organic products |
09/18/2012 | CA2374385C Detection of hiv-1 by nucleic acid amplification |
09/18/2012 | CA2369812C Mink-related genes, formation of potassium channels and association with cardiac arrhythmia |
09/18/2012 | CA2330313C Immunization against and treatment for infection by h.pylori |
09/18/2012 | CA2294962C Nucleic acid sequence analysis |
09/18/2012 | CA2291483C Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof |
09/18/2012 | CA2279554C Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
09/18/2012 | CA2272051C Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
09/18/2012 | CA2252972C Serum-free production of recombinant proteins and adenoviral vectors |
09/18/2012 | CA2221293C Helper virus-free aav production |
09/13/2012 | WO2012122571A1 Methods and compositions for the selection and optimization of oligonucleotide tag sequences |